Indapta Therapeutics

About:

Indapta Therapeutics is a privately held biotechnology company.

Top Investors: RA Capital Management, Cancer Prevention and Research Institute of Texas, Lonza, Vertex Ventures, Leaps by Bayer

Description:

Indapta Therapeutics is a privately held biotechnology company developing an NK (natural killer) cell therapy platform for the treatment of blood and solid tumor cancers.

Total Funding Amount:

$54.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2017-01-01

Founders:

Guy DiPierro, Ronald Martell

Number of Employees:

1-10

Last Funding Date:

2024-05-21

IPO Status:

Private

Industries: